Sorrento Therapeutics, Inc.

Ownership Transactions Reported by 9 Insiders

Symbol
SRNE on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
4955 Directors Place, San Diego, California

There are no Buy or Sell transactions made by insiders since 9/12/2023

Sorrento Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Henry Ji President, CEO and Chairman of the Board of Directors, Director $6.9M Mar 17, 2023
Robin L. Smith Director $189K Sep 3, 2021
Kim Janda Director $2.41K Dec 31, 2021
Jaisim Shah Director Aug 30, 2021
Yue Alexander Wu Director Aug 30, 2021
Tammy Reilly Director May 18, 2022
Elizabeth Czerepak EVP & Chief Financial Officer May 18, 2022
Dorman Followwill Director Aug 30, 2021
David Lemus Director Aug 30, 2021

Recent Insider Transactions by Companies or Individuals for Sorrento Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.